Machine learning predictions based on historical earnings data and price patterns
1-Day Prediction
-0.14%
$89.96
0% positive prob.
5-Day Prediction
-2.31%
$88.00
0% positive prob.
20-Day Prediction
+0.94%
$90.93
0% positive prob.
SEC 8-K filings with transcript text
Jan 30, 2026 · 100% conf.
1D
-0.14%
$89.96
Act: +2.01%
5D
-2.31%
$88.00
Act: +4.81%
20D
+0.94%
$90.93
cl-202601300000021665False00000216652026-01-302026-01-300000021665us-gaap:CommonStockMember2026-01-302026-01-300000021665cl:A0.500NotesDue2026Member2026-01-302026-01-300000021665cl:A0300NotesDue2029Member2026-01-302026-01-300000021665cl:A1.375NotesDue2034Member2026-01-302026-01-300000021665cl:A3.250NotesDue2035Member2026-01-302026-01-300000021665cl:A0.875Notesdue2039Member2026-01-302026-01-30
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 30, 2026
(Exact name of registrant as specified in its charter)
Delaware 1-644 13-1815595
(State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)
300 Park Avenue, New York,NY10022 (Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Securities 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $1.00 par value CL New York Stock Exchange
0.500% Notes due 2026
New York Stock Exchange
0.300% Notes due 2029
New York Stock Exchange
1.375% Notes due 2034
New York Stock Exchange
3.250% Notes due 2035
New York Stock Exchange
0.875% Notes due 2039
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On January 30, 2026, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter and year ended December 31, 2025. This press release is attached as Exhibit 99 and is incorporated herein by reference.
The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. The following exhibits are filed with this document:
Exhibit Number Description
99 Press release, dated January 30, 2026, issued by Colgate-Palmolive Company
104Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
>
Date: January 30, 2026 By: /s/ Stanley J. Sutula III
Name: Stanley J. Sutula III Title: Chief Financial Officer
3
Oct 31, 2025
cl-202510310000021665False00000216652025-10-312025-10-310000021665us-gaap:CommonStockMember2025-10-312025-10-310000021665cl:A0.500NotesDue2026Member2025-10-312025-10-310000021665cl:A0300NotesDue2029Member2025-10-312025-10-310000021665cl:A1.375NotesDue2034Member2025-10-312025-10-310000021665cl:A0.875Notesdue2039Member2025-10-312025-10-31
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 31, 2025
(Exact name of registrant as specified in its charter)
Delaware 1-644 13-1815595
(State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)
300 Park Avenue, New York,NY10022 (Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Securities 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $1.00 par value CL New York Stock Exchange
0.500% Notes due 2026
New York Stock Exchange
0.300% Notes due 2029
New York Stock Exchange
1.375% Notes due 2034
New York Stock Exchange
0.875% Notes due 2039
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On October 31, 2025, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter ended September 30, 2025. This press release is attached as Exhibit 99 and is incorporated herein by reference.
The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 2.05. Costs Associated with Exit or Disposal Activities.
As previously disclosed, on July 31, 2025, the Company’s Board of Directors approved a new three-year productivity program to drive future growth and support the Company’s 2030 strategy (the “Strategic Growth and Productivity Program”). The program includes initiatives to better align the Company’s organizational structure to support its strategic initiatives, optimize the Company’s global supply chain to drive agility and efficiencies and simplify and streamline its organizational structure to reduce overhead costs.
The Strategic Growth and Productivity Program is estimated to result in cumulative pre-tax charges, once all initiatives are approved and implemented, totaling between $200 and $300 million, which is currently estimated to be comprised of the following: employee-related costs, including severance and other termination benefits (65% to 75%) and asset-related costs and other charges (25% to 35%), which include accelerated depreciation, asset write-offs, contract termination and other exit costs. It is estimated that approximately 75% to 85% of the charges will result in cash expenditures and substantially all charges resulting from the program will be incurred by December 31, 2028.
It is estimated that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15% to 20%), Latin America (15% to 20%), Europe (10% to 15%), Asia Pacific (10% to 15%), Africa/Eurasia (5% to 10%), Hill’s Pet Nutrition (10% to 15%) and Corporate (10% to 15%).
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. The following exhibits are filed with this document:
Exhibit Number Description
99 Press release,
Aug 1, 2025
cl-202507310000021665False00000216652025-07-312025-07-310000021665us-gaap:CommonStockMember2025-07-312025-07-310000021665cl:A0.500NotesDue2026Member2025-07-312025-07-310000021665cl:A0300NotesDue2029Member2025-07-312025-07-310000021665cl:A1.375NotesDue2034Member2025-07-312025-07-310000021665cl:A0.875Notesdue2039Member2025-07-312025-07-31
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) August 1, 2025 (July 31, 2025)
(Exact name of registrant as specified in its charter)
Delaware 1-644 13-1815595
(State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)
300 Park Avenue, New York,NY10022 (Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Securities 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $1.00 par value CL New York Stock Exchange
0.500% Notes due 2026
New York Stock Exchange
0.300% Notes due 2029
New York Stock Exchange
1.375% Notes due 2034
New York Stock Exchange
0.875% Notes due 2039
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On August 1, 2025, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter ended June 30, 2025. This press release is attached as Exhibit 99 and is incorporated herein by reference.
The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 2.05. Costs Associated with Exit or Disposal Activities.
On July 31, 2025, the Company’s Board of Directors approved a new three-year productivity program to drive future growth and support the Company’s 2030 strategy (the “Productivity Program”).
The program includes initiatives to better align the Company’s organizational structure to support its strategic initiatives, optimize the Company’s global supply chain to drive agility and efficiencies and simplify and streamline its organizational structure to reduce overhead costs. The Productivity Program is projected to result in cumulative pre-tax charges, once all initiatives are approved and implemented, totaling between $200 and $300 million over the course of the three-year program. It is expected that substantially all charges resulting from the Productivity Program will be incurred by December 31, 2028.
Charges related to the Productivity Program will be recorded in the Corporate segment as these decisions are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance.
This Current Report on Form 8-K contains forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (“SEC”) in its rules, regulations and releases) about the Productivity Program. These statements are made on the basis of the Company’s views and assumptions as of this time and the Company undertakes no obligation to update these statements unless required by law. These statements are not guarantees of future performance; they involve risks and uncertainties and actual events or results may differ materially from these statements. Potential risks and
Apr 25, 2025
cl-202504250000021665False00000216652025-04-252025-04-250000021665us-gaap:CommonStockMember2025-04-252025-04-250000021665cl:A0.500NotesDue2026Member2025-04-252025-04-250000021665cl:A0300NotesDue2029Member2025-04-252025-04-250000021665cl:A1.375NotesDue2034Member2025-04-252025-04-250000021665cl:A0.875Notesdue2039Member2025-04-252025-04-25
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 25, 2025
(Exact name of registrant as specified in its charter)
Delaware 1-644 13-1815595
(State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)
300 Park Avenue, New York,NY10022 (Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Securities 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $1.00 par value CL New York Stock Exchange
0.500% Notes due 2026
New York Stock Exchange
0.300% Notes due 2029
New York Stock Exchange
1.375% Notes due 2034
New York Stock Exchange
0.875% Notes due 2039
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On April 25, 2025, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter ended March 31, 2025. This press release is attached as Exhibit 99 and is incorporated herein by reference.
The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. The following exhibits are filed with this document:
Exhibit Number Description
99 Press release, dated April 25, 2025, issued by Colgate-Palmolive Company
104 Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
2
Exhibit Number Description
99 Press release, dated April 25, 2025, issued by Colgate-Palmolive Company
104Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
3
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
>
Date: April 25, 2025 By: /s/ Stanley J. Sutula III
Name: Stanley J. Sutula III Title: Chief Financial Officer
4
Jan 31, 2025
cl-202501310000021665False00000216652025-01-312025-01-310000021665us-gaap:CommonStockMember2025-01-312025-01-310000021665cl:A0.500NotesDue2026Member2025-01-312025-01-310000021665cl:A0300NotesDue2029Member2025-01-312025-01-310000021665cl:A1.375NotesDue2034Member2025-01-312025-01-310000021665cl:A0.875Notesdue2039Member2025-01-312025-01-31
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 31, 2025
(Exact name of registrant as specified in its charter)
Delaware 1-644 13-1815595
(State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)
300 Park Avenue, New York,NY10022 (Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Securities 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $1.00 par value CL New York Stock Exchange
0.500% Notes due 2026
New York Stock Exchange
0.300% Notes due 2029
New York Stock Exchange
1.375% Notes due 2034
New York Stock Exchange
0.875% Notes due 2039
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On January 31, 2025, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter and year ended December 31, 2024. This press release is attached as Exhibit 99 and is incorporated herein by reference.
The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. The following exhibits are filed with this document:
Exhibit Number Description
99Press release, dated January 31, 2025, issued by Colgate-Palmolive Company
104Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
2
Exhibit Number Description
99 Press release, dated January 31, 2025, issued by Colgate-Palmolive Company
104Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
3
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
>
Date: January 31, 2025 By: /s/ Stanley J. Sutula III
Name: Stanley J. Sutula III Title: Chief Financial Officer
4
Jan 24, 2025
cl-202410250000021665False00000216652024-10-252024-10-250000021665us-gaap:CommonStockMember2024-10-252024-10-250000021665cl:A0.500NotesDue2026Member2024-10-252024-10-250000021665cl:A0300NotesDue2029Member2024-10-252024-10-250000021665cl:A1.375NotesDue2034Member2024-10-252024-10-250000021665cl:A0.875Notesdue2039Member2024-10-252024-10-25
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 25, 2024
(Exact name of registrant as specified in its charter)
Delaware 1-644 13-1815595
(State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)
300 Park Avenue, New York,NY10022 (Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Securities 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $1.00 par value CL New York Stock Exchange
0.500% Notes due 2026
New York Stock Exchange
0.300% Notes due 2029
New York Stock Exchange
1.375% Notes due 2034
New York Stock Exchange
0.875% Notes due 2039
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Explanatory Note
This Amendment No. 1 on Form 8-K/A is being filed by Colgate-Palmolive Company (the “Company”) solely to ensure an additional item number tag (Item 2.02) is reflected in the EDGAR system for the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission (“SEC”) on October 25, 2024 (the “Report”). No other changes are being made to the Report or to the exhibits attached thereto, including Exhibits 99.1 and 99.2
Item 2.02. Results of Operations and Financial Condition.
On October 25, 2024, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter ended September 30, 2024. This press release is attached as Exhibit 99.1 and is incorporated herein by reference.
The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 8.01. Other Events.
In connection with management changes, the Company realigned the reporting structure of its skin health business effective July 1, 2024. Accordingly, commencing with the Company’s financial reporting for the quarter ended September 30, 2024, the results of the skin health business previously reported within the Europe reportable operating segment are reported with the other skin health businesses in the North America reportable operating segment, with no impact on the Company's consolidated results of operations or financial position.
For information purposes and to provide investors with historical information on a basis consistent with its new reporting structure, the Company has recast its historical geographic segment information to conform to the new reporting structure.
Attached as Exhibit 99.2 and incorporated by reference in this Item 8.01 are schedules containing segment information by operating segment for the years ended December 31, 2023, 2022 and 2021, the three and six months ended June 30, 2024 and 2023, the three months ended March 31, 2024 and 2023 and the three months ended December 31, 2023.
As noted above, the segment change and supplemental disclosures discussed above have no impact on the Company’s historical consolidated financial posit
Jul 26, 2024
cl-202407260000021665False00000216652024-07-262024-07-260000021665us-gaap:CommonStockMember2024-07-262024-07-260000021665cl:A0.500NotesDue2026Member2024-07-262024-07-260000021665cl:A0300NotesDue2029Member2024-07-262024-07-260000021665cl:A1.375NotesDue2034Member2024-07-262024-07-260000021665cl:A0.875Notesdue2039Member2024-07-262024-07-26
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) July 26, 2024
(Exact name of registrant as specified in its charter)
Delaware 1-644 13-1815595
(State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)
300 Park Avenue, New York,NY10022 (Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Securities 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $1.00 par value CL New York Stock Exchange
0.500% Notes due 2026
New York Stock Exchange
0.300% Notes due 2029
New York Stock Exchange
1.375% Notes due 2034
New York Stock Exchange
0.875% Notes due 2039
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On July 26, 2024, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter ended June 30, 2024. This press release is attached as Exhibit 99 and is incorporated herein by reference.
The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. The following exhibits are filed with this document:
Exhibit Number Description
99 Press release, dated July 26, 2024, issued by Colgate-Palmolive Company
104 Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
2
Exhibit Number Description
99 Press release, dated July 26, 2024, issued by Colgate-Palmolive Company
104Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
3
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
>
Date: July 26, 2024 By: /s/ Stanley J. Sutula III
Name: Stanley J. Sutula III Title: Chief Financial Officer
4
Apr 26, 2024
cl-202404260000021665False00000216652024-04-262024-04-260000021665us-gaap:CommonStockMember2024-04-262024-04-260000021665cl:A0.500NotesDue2026Member2024-04-262024-04-260000021665cl:A0300NotesDue2029Member2024-04-262024-04-260000021665cl:A1.375NotesDue2034Member2024-04-262024-04-260000021665cl:A0.875Notesdue2039Member2024-04-262024-04-26
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 26, 2024
(Exact name of registrant as specified in its charter)
Delaware 1-644 13-1815595
(State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)
300 Park Avenue, New York,NY10022 (Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Securities 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $1.00 par value CL New York Stock Exchange
0.500% Notes due 2026
New York Stock Exchange
0.300% Notes due 2029
New York Stock Exchange
1.375% Notes due 2034
New York Stock Exchange
0.875% Notes due 2039
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On April 26, 2024, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter ended March 31, 2024. This press release is attached as Exhibit 99 and is incorporated herein by reference.
The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. The following exhibits are filed with this document:
Exhibit Number Description
99 Press release, dated April 26, 2024, issued by Colgate-Palmolive Company
104 Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
2
Exhibit Number Description
99 Press release, dated April 26, 2024, issued by Colgate-Palmolive Company
104Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
3
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
>
Date: April 26, 2024 By: /s/ Stanley J. Sutula III
Name: Stanley J. Sutula III Title: Chief Financial Officer
4
Jan 26, 2024
false000002166500000216652024-01-262024-01-260000021665cl:One375NotesDue2034Member2024-01-262024-01-260000021665cl:CommonStock100ParValueMember2024-01-262024-01-260000021665cl:Zero500NotesDue2026Member2024-01-262024-01-260000021665cl:Zero300NotesDue2029Member2024-01-262024-01-260000021665cl:Zero875NotesDue2039Member2024-01-262024-01-26
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 26, 2024
(Exact name of registrant as specified in its charter)
Delaware
1-644
13-1815595
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
300 Park Avenue, New York, New York
10022
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which
registered
Common Stock, $1.00 par value
CL
New York Stock Exchange
0.500% Notes due 2026
New York Stock Exchange
0.300% Notes due 2029
New York Stock Exchange
1.375% Notes due 2034
New York Stock Exchange
0.875% Notes due 2039
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.
Results of Operations and Financial Condition.
On January 26, 2024, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter and year ended December 31, 2023. This press release is attached as Exhibit 99 and is incorporated herein by reference.
The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 9.01.
Financial Statements and Exhibits.
(d)
Exhibits. The following exhibits are filed with this document:
Exhibit Number
Description
99
Press release, dated January 26, 2024, issued by Colgate-Palmolive Company
104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
Exhibit Number
Description
99
Press release, dated January 26, 2024, issued by Colgate-Palmolive Company
104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: January 26, 2024
By: /s/ Stanley J. Sutula III
Name: Stanley J. Sutula III
Title: Chief Financial Officer
Oct 27, 2023
false000002166500000216652023-10-272023-10-270000021665cl:One375NotesDue2034Member2023-10-272023-10-270000021665cl:CommonStock100ParValueMember2023-10-272023-10-270000021665cl:Zero500NotesDue2026Member2023-10-272023-10-270000021665cl:Zero300NotesDue2029Member2023-10-272023-10-270000021665cl:Zero875NotesDue2039Member2023-10-272023-10-27
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 27, 2023
(Exact name of registrant as specified in its charter)
Delaware
1-644
13-1815595
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
300 Park Avenue, New York, New York
10022
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which
registered
Common Stock, $1.00 par value
CL
New York Stock Exchange
0.500% Notes due 2026
New York Stock Exchange
0.300% Notes due 2029
New York Stock Exchange
1.375% Notes due 2034
New York Stock Exchange
0.875% Notes due 2039
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.
Results of Operations and Financial Condition.
On October 27, 2023, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter ended September 30, 2023. This press release is attached as Exhibit 99 and is incorporated herein by reference.
The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 9.01.
Financial Statements and Exhibits.
(d)
Exhibits. The following exhibits are filed with this document:
Exhibit Number
Description
99
Press release, dated October 27, 2023, issued by Colgate-Palmolive Company
104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
Exhibit Number
Description
99
Press release, dated October 27, 2023, issued by Colgate-Palmolive Company
104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: October 27, 2023
By: /s/ Stanley J. Sutula III
Name: Stanley J. Sutula III
Title: Chief Financial Officer
Jul 28, 2023
false000002166500000216652023-07-282023-07-280000021665cl:One375NotesDue2034Member2023-07-282023-07-280000021665cl:CommonStock100ParValueMember2023-07-282023-07-280000021665cl:Zero500NotesDue2026Member2023-07-282023-07-280000021665cl:Zero300NotesDue2029Member2023-07-282023-07-280000021665cl:Zero875NotesDue2039Member2023-07-282023-07-28
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) July 28, 2023
(Exact name of registrant as specified in its charter)
Delaware
1-644
13-1815595
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
300 Park Avenue, New York, New York
10022
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which
registered
Common Stock, $1.00 par value
CL
New York Stock Exchange
0.500% Notes due 2026
New York Stock Exchange
0.300% Notes due 2029
New York Stock Exchange
1.375% Notes due 2034
New York Stock Exchange
0.875% Notes due 2039
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.
Results of Operations and Financial Condition.
On July 28, 2023, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter ended June 30, 2023. This press release is attached as Exhibit 99 and is incorporated herein by reference.
The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 9.01.
Financial Statements and Exhibits.
(d)
Exhibits. The following exhibits are filed with this document:
Exhibit Number
Description
99
Press release, dated July 28, 2023, issued by Colgate-Palmolive Company
104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
2
Exhibit Number
Description
99
Press release, dated July 28, 2023, issued by Colgate-Palmolive Company
104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
3
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 28, 2023
By:
/s/ Stanley J. Sutula III
Name: Stanley J. Sutula III
Title: Chief Financial Officer
4
Apr 28, 2023
false000002166500000216652023-04-282023-04-280000021665cl:One375NotesDue2034Member2023-04-282023-04-280000021665cl:CommonStock100ParValueMember2023-04-282023-04-280000021665cl:Zero500NotesDue2026Member2023-04-282023-04-280000021665cl:Zero300NotesDue2029Member2023-04-282023-04-280000021665cl:Zero875NotesDue2039Member2023-04-282023-04-28
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 28, 2023
(Exact name of registrant as specified in its charter)
Delaware
1-644
13-1815595
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
300 Park Avenue, New York, New York
10022
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which
registered
Common Stock, $1.00 par value
CL
New York Stock Exchange
0.500% Notes due 2026
New York Stock Exchange
0.300% Notes due 2029
New York Stock Exchange
1.375% Notes due 2034
New York Stock Exchange
0.875% Notes due 2039
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.
Results of Operations and Financial Condition.
On April 28, 2023, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter ended March 31, 2023. This press release is attached as Exhibit 99 and is incorporated herein by reference.
The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 9.01.
Financial Statements and Exhibits.
(d)
Exhibits. The following exhibits are filed with this document:
Exhibit Number
Description
99
Press release, dated April 28, 2023, issued by Colgate-Palmolive Company
104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
2
Exhibit Number
Description
99
Press release, dated April 28, 2023, issued by Colgate-Palmolive Company
104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
3
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: April 28, 2023
By: /s/ Stanley J. Sutula III
Name: Stanley J. Sutula III
Title: Chief Financial Officer
4
Jan 27, 2023
false000002166500000216652023-01-272023-01-270000021665cl:One375NotesDue2034Member2023-01-272023-01-270000021665cl:CommonStock100ParValueMember2023-01-272023-01-270000021665cl:Zero500NotesDue2026Member2023-01-272023-01-270000021665cl:Zero300NotesDue2029Member2023-01-272023-01-270000021665cl:Zero875NotesDue2039Member2023-01-272023-01-27
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 27, 2023
(Exact name of registrant as specified in its charter)
Delaware
1-644
13-1815595
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
300 Park Avenue, New York, New York
10022
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which
registered
Common Stock, $1.00 par value
CL
New York Stock Exchange
0.500% Notes due 2026
New York Stock Exchange
0.300% Notes due 2029
New York Stock Exchange
1.375% Notes due 2034
New York Stock Exchange
0.875% Notes due 2039
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.
Results of Operations and Financial Condition.
On January 27, 2023, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter and year ended December 31, 2022. This press release is attached as Exhibit 99 and is incorporated herein by reference.
The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 9.01.
Financial Statements and Exhibits.
(d)
Exhibits. The following exhibits are filed with this document:
Exhibit Number
Description
99
Press release, dated January 27, 2023, issued by Colgate-Palmolive Company
104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
2
Exhibit Number
Description
99
Press release, dated January 27, 2023, issued by Colgate-Palmolive Company
104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
3
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: January 27, 2023
By: /s/ Stanley J. Sutula III
Name: Stanley J. Sutula III
Title: Chief Financial Officer
4
Oct 28, 2022
false000002166500000216652022-10-282022-10-280000021665cl:One375NotesDue2034Member2022-10-282022-10-280000021665cl:CommonStock100ParValueMember2022-10-282022-10-280000021665cl:Zero500NotesDue2026Member2022-10-282022-10-280000021665cl:Zero300NotesDue2029Member2022-10-282022-10-280000021665cl:Zero875NotesDue2039Member2022-10-282022-10-28
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 28, 2022
(Exact name of registrant as specified in its charter)
Delaware
1-644
13-1815595
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
300 Park Avenue, New York, New York
10022
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which
registered
Common Stock, $1.00 par value
CL
New York Stock Exchange
0.500% Notes due 2026
New York Stock Exchange
0.300% Notes due 2029
New York Stock Exchange
1.375% Notes due 2034
New York Stock Exchange
0.875% Notes due 2039
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.
Results of Operations and Financial Condition.
On October 28, 2022, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter ended September 30, 2022. This press release is attached as Exhibit 99 and is incorporated herein by reference.
The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 9.01.
Financial Statements and Exhibits.
(d)
Exhibits. The following exhibits are filed with this document:
Exhibit Number
Description
99
Press release, dated October 28, 2022, issued by Colgate-Palmolive Company
104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
2
Exhibit Number
Description
99
Press release, dated October 28, 2022, issued by Colgate-Palmolive Company
104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
3
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: October 28, 2022
By: /s/ Stanley J. Sutula III
Name: Stanley J. Sutula III
Title: Chief Financial Officer
4
Jul 29, 2022
false000002166500000216652022-07-292022-07-290000021665cl:One375NotesDue2034Member2022-07-292022-07-290000021665cl:CommonStock100ParValueMember2022-07-292022-07-290000021665cl:Zero500NotesDue2026Member2022-07-292022-07-290000021665cl:Zero300NotesDue2029Member2022-07-292022-07-290000021665cl:Zero875NotesDue2039Member2022-07-292022-07-29
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) July 29, 2022
(Exact name of registrant as specified in its charter)
Delaware
1-644
13-1815595
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
300 Park Avenue, New York, New York
10022
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which
registered
Common Stock, $1.00 par value
CL
New York Stock Exchange
0.500% Notes due 2026
New York Stock Exchange
0.300% Notes due 2029
New York Stock Exchange
1.375% Notes due 2034
New York Stock Exchange
0.875% Notes due 2039
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.
Results of Operations and Financial Condition.
On July 29, 2022, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter ended June 30, 2022. This press release is attached as Exhibit 99 and is incorporated herein by reference.
The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 9.01.
Financial Statements and Exhibits.
(d)
Exhibits. The following exhibits are filed with this document:
Exhibit Number
Description
99
Press release, dated July 29, 2022, issued by Colgate-Palmolive Company
104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
Exhibit Number
Description
99
Press release, dated July 29, 2022, issued by Colgate-Palmolive Company
104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 29, 2022
By: /s/ Stanley J. Sutula III
Name: Stanley J. Sutula III
Title: Chief Financial Officer
Apr 29, 2022
false000002166500000216652022-04-292022-04-290000021665cl:One375NotesDue2034Membercl:NewYorkStockExchangeMember2022-04-292022-04-290000021665cl:Zero500NotesDue2026Membercl:NewYorkStockExchangeMember2022-04-292022-04-290000021665cl:CommonStock100ParValueMembercl:NewYorkStockExchangeMember2022-04-292022-04-290000021665cl:Zero300NotesDue2029Membercl:TheNewYorkStockExchangeMember2022-04-292022-04-290000021665cl:Zero875NotesDue2039Membercl:NewYorkStockExchangeMember2022-04-292022-04-29
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 29, 2022
(Exact name of registrant as specified in its charter)
Delaware
1-644
13-1815595
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
300 Park Avenue, New York, New York
10022
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which
registered
Common Stock, $1.00 par value
CL
New York Stock Exchange
0.500% Notes due 2026
New York Stock Exchange
0.300% Notes due 2029
New York Stock Exchange
1.375% Notes due 2034
New York Stock Exchange
0.875% Notes due 2039
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.
Results of Operations and Financial Condition.
On April 29, 2022, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter ended March 31, 2022. This press release is attached as Exhibit 99 and is incorporated herein by reference.
The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 9.01.
Financial Statements and Exhibits.
(d)
Exhibits.
The following exhibits are filed with this document:
Exhibit Number
Description
99
Press release, dated April 29, 2022, issued by Colgate-Palmolive Company
104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
2
Exhibit Number
Description
99
Press release, dated April 29, 2022, issued by Colgate-Palmolive Company
104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
3
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: April 29, 2022
By: /s/ Stanley J. Sutula III
Name: Stanley J. Sutula III
Title: Chief Financial Officer
4
Jan 28, 2022
false000002166500000216652022-01-282022-01-280000021665cl:Zero500NotesDue2026Member2022-01-282022-01-280000021665cl:One375NotesDue2034Member2022-01-282022-01-280000021665cl:Zero875NotesDue2039Member2022-01-282022-01-280000021665cl:CommonStock100ParValueMember2022-01-282022-01-28
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 28, 2022
(Exact name of registrant as specified in its charter)
Delaware
1-644
13-1815595
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
300 Park Avenue, New York, New York
10022
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which
registered
Common Stock, $1.00 par value
CL
New York Stock Exchange
0.500% Notes due 2026
New York Stock Exchange
1.375% Notes due 2034
New York Stock Exchange
0.875% Notes due 2039
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.
Results of Operations and Financial Condition.
On January 28, 2022, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter and year ended December 31, 2021. This press release is attached as Exhibit 99 and is incorporated herein by reference.
The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 2.05.
Costs Associated with Exit or Disposal Activities.
On January 27, 2022, the Company’s Board of Directors approved a targeted productivity program (the “2022 Global Productivity Initiative”). The program is intended to reallocate resources toward the Company’s strategic priorities and faster growth businesses, drive efficiencies in the Company’s operations and streamline the Company’s supply chain to reduce structural costs.
Implementation of the 2022 Global Productivity Initiative, which is expected to be substantially completed by December 31, 2022, is projected to result in cumulative pre-tax charges, once all phases are approved and implemented, totaling between $200 and $240 million, which are currently estimated to be comprised of the following: employee-related costs, including severance, pension and other termination benefits (80%); asset-related costs, primarily accelerated depreciation and asset write-downs (10%); and other charges (10%), which include contract termination costs, consisting primarily of implementation-related charges resulting directly from exit activities and the implementation of new strategies. It is estimated that approximately 90% of the charges will result in cash expenditures.
Charges related to the 2022 Global Productivity Initiative will be recorded in the Corporate segment as these decisions are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance.
This Current Report on Form 8-K contains forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (“SEC”) in its rules, regulations and releases) about the 2022 Global Productivity Initiative. These statements are made on the basis of the Company
Oct 29, 2021
false000002166500000216652021-10-292021-10-290000021665cl:One375NotesDue2034Member2021-10-292021-10-290000021665cl:Zero500NotesDue2026Member2021-10-292021-10-290000021665cl:CommonStock100ParValueMember2021-10-292021-10-290000021665cl:Zero875NotesDue2039Member2021-10-292021-10-29
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 29, 2021
(Exact name of registrant as specified in its charter)
Delaware
1-644
13-1815595
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
300 Park Avenue, New York, New York
10022
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which
registered
Common Stock, $1.00 par value
CL
New York Stock Exchange
0.500% Notes due 2026
New York Stock Exchange
1.375% Notes due 2034
New York Stock Exchange
0.875% Notes due 2039
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.
Results of Operations and Financial Condition.
On October 29, 2021, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter ended September 30, 2021. This press release is attached as Exhibit 99 and is incorporated herein by reference.
The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 9.01.
Financial Statements and Exhibits.
(d)
Exhibits. The following exhibits are filed with this document:
Exhibit Number
Description
99
Press release, dated October 29, 2021, issued by Colgate-Palmolive Company
104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: October 29, 2021
By:
/s/ Stanley J. Sutula III
Name: Stanley J. Sutula III
Title: Chief Financial Officer
3
Exhibit Number
Description
99
Press release, dated October 29, 2021, issued by Colgate-Palmolive Company
104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
4
Jul 30, 2021
false000002166500000216652021-07-302021-07-300000021665cl:Zero500NotesDue2026Member2021-07-302021-07-300000021665cl:Zero875NotesDue2039Member2021-07-302021-07-300000021665cl:One375NotesDue2034Member2021-07-302021-07-300000021665cl:Zero000NotesDue2021Member2021-07-302021-07-300000021665cl:CommonStock100ParValueMember2021-07-302021-07-30
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) (July 30, 2021)
(Exact name of registrant as specified in its charter)
Delaware
1-644
13-1815595
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
300 Park Avenue, New York, New York
10022
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which
registered
Common Stock, $1.00 par value
CL
New York Stock Exchange
0.000% Notes due 2021
New York Stock Exchange
0.500% Notes due 2026
New York Stock Exchange
1.375% Notes due 2034
New York Stock Exchange
0.875% Notes due 2039
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.
Results of Operations and Financial Condition.
On July 30, 2021, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter ended June 30, 2021. This press release is attached as Exhibit 99 and is incorporated herein by reference.
The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 9.01.
Financial Statements and Exhibits.
(d)
Exhibits. The following exhibits are filed with this document:
Exhibit Number
Description
99
Press release, dated July 30, 2021, issued by Colgate-Palmolive Company
104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 30, 2021
By: /s/ Stanley J. Sutula III
Name: Stanley J. Sutula III
Title: Chief Financial Officer
3
Exhibit Number
99
Description
Press release, dated July 30, 2021, issued by Colgate-Palmolive Company
104
Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
4
Apr 30, 2021
cl-202104300000021665FALSE00000216652021-04-302021-04-300000021665us-gaap:CommonStockMember2021-04-302021-04-300000021665cl:A0000NotesDue2021Member2021-04-302021-04-300000021665cl:A0500NotesDue2026Member2021-04-302021-04-300000021665cl:A1375NotesDue2034Member2021-04-302021-04-300000021665cl:A0875NotesDue2039Member2021-04-302021-04-30
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 30, 2021
(Exact name of registrant as specified in its charter)
Delaware1-64413-1815595 (State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification No.)
300 Park Avenue New York,New York10022 (Address of Principal Executive Offices)(Zip Code)
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $1.00 par valueCLNew York Stock Exchange 0.000% Notes due 2021CL21ANew York Stock Exchange 0.500% Notes due 2026CL26New York Stock Exchange 1.375% Notes due 2034CL34New York Stock Exchange 0.875% Notes due 2039CL39New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
This Amendment No. 1 on Form 8-K/A amends and restates the Current Report on Form 8-K filed on April 30, 2021 (the “Report”) by Colgate-Palmolive Company (the “Company”) in order to correct a clerical error in Table 3, Condensed Consolidated Statements of Cash Flows, that is part of the press release attached as Exhibit 99 to the Report, in which one line item (Dividends paid) was inadvertently omitted therefrom. No other changes are being made to the Report or to the press release attached as Exhibit 99 thereto.
Item 2.02. Results of Operations and Financial Condition.
On April 30, 2021, the Company issued a press release announcing its earnings for the quarter ended March 31, 2021. This press release is attached as Exhibit 99 and is incorporated herein by reference.
The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. The following exhibits are filed with this document:
Exhibit Number Description
99 Press release, dated April 30, 2021, issued by Colgate-Palmolive Company
104 Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)
Exhibit Number Description
99 Press release, dated April 30, 2021, issued by Colgate-Palmolive Company
104 Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document) 3
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: April 30, 2021 By: /s/ Stanley J. Sutula III
Name: Stanley J. Sutula III Title: Chief Financial Officer
This page provides Colgate-Palmolive Company (CL) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.
Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on CL's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.